Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia

被引:282
作者
Lurain, John R. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, John I Brewer Trophoblast Dis Ctr, Chicago, IL 60611 USA
关键词
chemotherapy; choriocarcinoma; gestational trophoblastic disease; gestational trophoblastic neoplasia; WEEKLY INTRAMUSCULAR METHOTREXATE; SINGLE-AGENT METHOTREXATE; LOW-DOSE METHOTREXATE; ACTINOMYCIN-D; FOLINIC ACID; PRIMARY THERAPY; VINCRISTINE CHEMOTHERAPY; PREGNANCY OUTCOMES; PULSE METHOTREXATE; EMA/CO ETOPOSIDE;
D O I
10.1016/j.ajog.2010.06.072
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Gestational trophoblastic neoplasia (GTN) includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. The overall cure rate in treating these tumors is currently >90%. Thorough evaluation and staging allow selection of appropriate therapy that maximizes chances for cure while minimizing toxicity. Nonmetastatic (stage I) and low-risk metastatic (stages II and III, score <7) GTN can be treated with single-agent chemotherapy resulting in a survival rate approaching 100%. High-risk GTN (stages II-IV, score >= 7) requires initial multiagent chemotherapy with or without adjuvant radiation and surgery to achieve a survival rate of 80-90%.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 95 条
[1]   Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens [J].
Abrao, Renato Antonio ;
de Andrade, Jurandyr Moreira ;
Tiezzi, Daniel Guimaraes ;
Cosiski Marana, Heitor Ricardo ;
Candido dos Reis, Francisco Jose ;
Clagnan, Willian Simoes .
GYNECOLOGIC ONCOLOGY, 2008, 108 (01) :149-153
[2]  
Alazzam M, 2009, COCHRANE DB SYST REV, V1
[3]  
Alazzam M, 2008, J REPROD MED, V53, P519
[4]   THE ROLE OF LOW-DOSE METHOTREXATE AND FOLINIC ACID IN GESTATIONAL TROPHOBLASTIC TUMORS (GTT) [J].
BAGSHAWE, KD ;
DENT, J ;
NEWLANDS, ES ;
BEGENT, RHJ ;
RUSTIN, GJS .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (07) :795-802
[5]  
BAKRI Y, 1994, J REPROD MED, V39, P179
[6]  
BEGENT RHJ, 1982, SEMIN ONCOL, V9, P198
[7]   Current management of gestational trophoblastic diseases [J].
Berkowitz, Ross S. ;
Goldstein, Donald P. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (03) :654-662
[8]   METHOTREXATE INFUSION AND FOLINIC ACID IN THE PRIMARY THERAPY OF NONMETASTATIC GESTATIONAL TROPHOBLASTIC TUMORS [J].
BERKOWITZ, RS ;
GOLDSTEIN, DP ;
BERNSTEIN, MR .
GYNECOLOGIC ONCOLOGY, 1990, 36 (01) :56-59
[9]   10-YEARS EXPERIENCE WITH METHOTREXATE AND FOLINIC ACID AS PRIMARY THERAPY FOR GESTATIONAL TROPHOBLASTIC DISEASE [J].
BERKOWITZ, RS ;
GOLDSTEIN, DP ;
BERNSTEIN, MR .
GYNECOLOGIC ONCOLOGY, 1986, 23 (01) :111-118
[10]   EMA/CO REGIMEN IN HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMOR (GTT) [J].
BOLIS, G ;
BONAZZI, C ;
LANDONI, F ;
MANGILI, G ;
VERGADORO, F ;
ZANABONI, F ;
MANGIONI, C .
GYNECOLOGIC ONCOLOGY, 1988, 31 (03) :439-444